Sonia Maria Poli
Net worth: 84 324 $ as of 2026-05-30
Net worth: 84 324 $ as of 2026-05-30
Sonia Maria Poli is currently Independent Non-Executive Director at Dimerix Ltd. since 2015 and Managing Director & Director at Dimerix Bioscience Pty Ltd. since 2014.
Former roles include Global Head-Multidimensional Optimization at F.
Hoffmann-La Roche Ltd. in 2004, Chief Scientific Officer & Head-Development at Addex Therapeutics Ltd. from 2013 to 2017, Head-Translational Science at AC Immune SA from 2017 to 2019, Chief Scientific Officer at Minoryx Therapeutics SL from 2019 to 2020, and Chief Scientific Officer at Sibylla Biotech SpA from 2023 to 2024.
Education includes graduate and doctorate degrees from the University of Milan, conferred in 1990 and 1993 respectively.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
DIMERIX LIMITED 0.11% | 2025-12-11 | 633,490 ( 0.11% ) | 84 324 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| DIMERIX LIMITED | Director/Board Member | 2015-07-02 |
Dimerix Bioscience Pty Ltd.
Dimerix Bioscience Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops therapy for chronic kidney disease | Chief Executive Officer | 2014-04-30 |
| Companies | Position | End |
|---|---|---|
Sibylla Biotech Srl
Sibylla Biotech Srl Internet Software/ServicesTechnology Services Operates drug discovery platform | Chief Tech/Sci/R&D Officer | 2024-07-31 |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Develops pharmaceutical products | Chief Tech/Sci/R&D Officer | - |
| ADDEX THERAPEUTICS LTD | Chief Tech/Sci/R&D Officer | 2017-08-31 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 2003-12-31 |
| AC IMMUNE SA | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
AC Immune SA
AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
Addex Therapeutics Ltd.
Addex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs | Health Technology |
University of Milan
University of Milan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dimerix Ltd.
Dimerix Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of biopharmaceutical drugs | Health Technology |
Dimerix Bioscience Pty Ltd.
Dimerix Bioscience Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops therapy for chronic kidney disease | Health Technology |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
Sibylla Biotech Srl
Sibylla Biotech Srl Internet Software/ServicesTechnology Services Operates drug discovery platform | Technology Services |
Select your edition
All financial news and data tailored to specific country editions